MAPK1 and cerebral malformation: Although activating mutations of HRAS can result in increased ERK phosphorylation and uncontrolled EC proliferation, resulting in cerebrovascular malformations in a mouse model [295], KRAS mutations observed in human brain malformations did influence ERK activation and angiogenic marker expression but not EC proliferation [288].